We are focused on bringing psychedelic medicine to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing.
Developing psychedelic inspired medicines and experiential therapies to help tap into the mind's own healing capabilities

Core One Labs is a leading life sciences company

A new type of pharma company focused on overall patient health
Mental health and addiction is a growing problem for people around the world and we are working on a solution.
Highlights
We are focused on advancing the use of psychedelic medicines through novel delivery systems, specialized assisted psychotherapy, and API grade psilocybin manufacturing.
Get News Alerts
Enter your email address to get Core One Labs news alerts
Company News
26 February, 2021
Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin
24 February, 2021
Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments
10 February, 2021
Core One Labs Highlights Key Points From International Investor Call
10 February, 2021
Core One Labs Prepares First in Series of Patent Applications